61
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Administering the Routine Activities domain of the Oxford Participation and Activities Questionnaire as a stand-alone scale: the Oxford Routine Activities Measure

, , &
Pages 239-243 | Published online: 25 Jul 2018

References

  • World Health OrganisationInternational Classification of Functioning, Disability and HealthGenevaWorld Health Organisation2001
  • KellyLJenkinsonCDummettSDawsonJFitzpatrickRMorleyDDevelopment of the Oxford Participation and Activities Questionnaire: constructing an item poolPatient Relat Outcome Meas2015614515526056503
  • KellyLDummettSDawsonJFitzpatrickRJenkinsonCMorleyDGenerating items for the Oxford Participation and Activities Questionnaire (Ox-PAQ)Qual Life Res201423Suppl 18182
  • MorleyDDummettSKellyLDawsonJFitzpatrickRJenkinsonCPretesting the Oxford Participation and Activities Questionnaire: results from an expert reviewMov Disord201530Suppl 1S419
  • Food and Drug Administration, Department of Health and Human SciencesGuidance to Industry Patient Reported Outcome Measures Use in Medical Product Development to Support Labelling ClaimsSilver Spring, MDFood and Drug Administration2009
  • EMAReflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products2004 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003637.pdfAccessed November 1, 2017
  • MorleyDDummettSKellyLDawsonJFitzpatrickRJenkinsonCValidation of the Oxford Participation and Activities QuestionnairePatient Relat Outcome Meas20167738027366108
  • MorleyDDummettSDawsonJThe Oxford Participation and Activities Questionnaire (Ox-PAQ): psychometric analysisValue Health2015187A742
  • KellyLDummettSDawsonJFitzpatrickRJenkinsonCMorleyDPsychometric evaluation of the Oxford participation and activities questionnaire (Ox-PAQ)J Neurol Sci2015357357 Suppl 1e273
  • SackleyCMWalkerMFBurtonCRAn occupational therapy intervention for residents with stroke related disabilities in UK care homes (OTCH): cluster randomised controlled trialBMJ2015350h46825657106
  • RodgersHShawLCantREvaluating an extended rehabilitation service for stroke patients (EXTRAS): study protocol for a randomised controlled trialTrials20151620525939584
  • DesveauxLBeauchampMKLeeAIversNGoldsteinRBrooksDEffects of a Community-Based, Post-Rehabilitation Exercise Program in COPD: Protocol for a Randomized Controlled Trial With Embedded Process EvaluationJMIR Res Protoc201652e6327169436
  • HornslienAGSandsetECWyllerTBBergeEScandinavian Candesartan Acute Stroke Trial (SCAST) Study Group. Effects of candesartan in acute stroke on activities of daily living and level of care at 6 monthsJ Hypertens20153371487149126039534
  • Qualtrics, 20052017Provo, UT, USA
  • KellyLDummettSDawsonJPretesting An E-Based Version Of The Oxford Participation & Activities Questionnaire (Ox-Paq)Value Health2016197A485
  • IBMCRIBM SPSS Statistics for Windows, Version 24.0Armonk, NYIBM Corp2016
  • KaiserHFA second generation little jiffyPsychometrika1970354401415
  • KaiserHFRiceJLittle JiffyMIVEduc Psychol Meas1974341111117
  • BartlettMSTests of significance in factor analysisBritish Journal of Statistical Psychology1950327785
  • CronbachLJCoefficient alpha and the internal structure of testsPsychometrika1951163297334
  • TukeyJWComparing individual means in the analysis of varianceBiometrics1949529911418151955
  • PetoVJenkinsonCFitzpatrickRGreenhallRThe development and validation of a short measure of functioning and well being for individuals with Parkinson’s diseaseQual Life Res1995432412487613534
  • JenkinsonCFitzpatrickRBrennanCBrombergMSwashMThe amyotrophic lateral sclerosis assessment questionnaire (ALSAQ-40): tests of data quality, score reliability and response rate in a survey of patientsJ Neurol1999246Suppl 3III16III2110631656
  • KlinePA general description of factor analysisKlinePAn Easy Guide to Factor AnalysisLondonRoutledge1994113
  • EstabrooksCASquiresJEHaydukLACummingsGGNortonPGAdvancing the argument for validity of the Alberta Context Tool with healthcare aides in residential long-term careBMC Med Res Methodol20111110721767378
  • AaronsonNAlonsoJBurnamAAssessing health status and quality-of-life instruments: attributes and review criteriaQual Life Res200211319320512074258
  • BrazierJDeverillMA checklist for judging preference-based measures of health related quality of life: learning from psychometricsHealth Econ199981415110082142
  • MorleyDSelaiCSchragAThompsonAJJahanshahiMRefinement and validation of the Parental Illness Impact ScaleParkinsonism Relat Disord201016318118519939722
  • PapaioannouDBrazierJParryGHow valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? A systematic reviewValue Health201114690792021914513
  • MorleyDDummettSKellyLDawsonJJenkinsonCEvaluating the psychometric properties of an e-based version of the 39-item Parkinson’s Disease QuestionnaireHealth Qual Life Outcomes201513525613007
  • RiaziAHobartJCLampingDLUsing the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson’s disease with normal population health profilesJ Neurol Neurosurg Psychiatry200374671071412754336
  • MorleyDSelaiCThompsonAQuality of life and psychosocial well-being in people with multiple sclerosis and Parkinson’s disease2007 International Society for Quality of Life Research Meeting AbstractsQual Life Res2007 A-114–Abstract #1393